Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Novak

Showing results (201-210 of 230) with videos related to

Pageof 23
Sort By:
Developmental Cell|March 4, 2014
Germline quality control: eEF2K stands guard to eliminate defective oocytesHsueh-Ping Chu, Yi Liao, James S Novak, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
Mutagenesis Sensitivity Mapping of Human Enhancers <i>In Vivo</i>Michael Kosicki, Boyang Zhang, Anusri Pampari, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 4, 2017
Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular DystrophyYusuke Echigoya, Kenji Rowel Q Lim, Nhu Trieu, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 16, 2021
Characterization of Mammalian In Vivo Enhancers Using Mouse Transgenesis and CRISPR Genome EditingMarco Osterwalder, Stella Tran, Riana D Hunter, et al.
Aging Cell|June 5, 2021
Human muscle stem cells are refractory to agingJames S Novak, Davi A G Mázala, Marie Nearing, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Massively parallel reporter assays and mouse transgenic assays provide complementary information about neuronal enhancer activityMichael Kosicki, Dianne Laboy Cintrón, Nicholas F Page, et al.
Human Molecular Genetics|November 15, 2015
Effect of genetic background on the dystrophic phenotype in mdx miceWilliam D Coley, Laurent Bogdanik, Maria Candida Vila, et al.
International Journal of Audiology|September 4, 2025
Audiological outcomes of the Cochlear Osia 2 bone conduction system implanted under expanded indications in a pediatric populationViral D Tejani, Shawn Stevens, Abby Meyer, et al.
Science Translational Medicine|July 14, 2017
HIF activation causes synthetic lethality between the <i>VHL</i> tumor suppressor and the <i>EZH1</i> histone methyltransferaseAbhishek A Chakraborty, Eijiro Nakamura, Jun Qi, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2018
Autochthonous tumors driven by <i>Rb1</i> loss have an ongoing requirement for the RBP2 histone demethylaseSamuel K McBrayer, Benjamin A Olenchock, Gabriel J DiNatale, et al.
Pageof 23

Showing results (201-210 of 230) with videos related to

Sort By:
Pageof 23
Developmental Cell|March 4, 2014
Germline quality control: eEF2K stands guard to eliminate defective oocytesHsueh-Ping Chu, Yi Liao, James S Novak, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
Mutagenesis Sensitivity Mapping of Human Enhancers <i>In Vivo</i>Michael Kosicki, Boyang Zhang, Anusri Pampari, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 4, 2017
Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular DystrophyYusuke Echigoya, Kenji Rowel Q Lim, Nhu Trieu, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 16, 2021
Characterization of Mammalian In Vivo Enhancers Using Mouse Transgenesis and CRISPR Genome EditingMarco Osterwalder, Stella Tran, Riana D Hunter, et al.
Aging Cell|June 5, 2021
Human muscle stem cells are refractory to agingJames S Novak, Davi A G Mázala, Marie Nearing, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Massively parallel reporter assays and mouse transgenic assays provide complementary information about neuronal enhancer activityMichael Kosicki, Dianne Laboy Cintrón, Nicholas F Page, et al.
Human Molecular Genetics|November 15, 2015
Effect of genetic background on the dystrophic phenotype in mdx miceWilliam D Coley, Laurent Bogdanik, Maria Candida Vila, et al.
International Journal of Audiology|September 4, 2025
Audiological outcomes of the Cochlear Osia 2 bone conduction system implanted under expanded indications in a pediatric populationViral D Tejani, Shawn Stevens, Abby Meyer, et al.
Science Translational Medicine|July 14, 2017
HIF activation causes synthetic lethality between the <i>VHL</i> tumor suppressor and the <i>EZH1</i> histone methyltransferaseAbhishek A Chakraborty, Eijiro Nakamura, Jun Qi, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2018
Autochthonous tumors driven by <i>Rb1</i> loss have an ongoing requirement for the RBP2 histone demethylaseSamuel K McBrayer, Benjamin A Olenchock, Gabriel J DiNatale, et al.
Pageof 23